CDSCO monthly lab alert
CDSCO NSQ alert, April 2026: 121 drug batches flagged
By Blacklisted editorial team· Published 20 May 2026· Updated 3 Nov 2026· Source: CDSCO NSQ portal
In its April 2026 alert, the Central Drugs Standard Control Organisation listed 121 drug batches that failed quality tests, 42 at central laboratories and 79 at state drug-testing laboratories, from 105 manufacturers across 90 products. The most common failure was assay, and the most-represented manufacturing state was Himachal Pradesh. Products flagged include Amoxycillin and Potassium Clavulanate Tablets IP, Albendazole Tablets I.P. 400 mg, Paracetamol Tablets IP 650 mg.
Batches per month, last 12 alerts
Full list of NSQ batches, April 2026
Download CSV| Product | Batch | Manufacturer | Reason declared NSQ | Tested by |
|---|---|---|---|---|
| Xylometazoline Hydrochloride Nasal Drops IP | Batch E25057Mfg Jul 2025 · Exp Jun 2027 | Agron Remedies Pvt. LtdUttarakhand | The sample does not conform to IP with respect to test for pH and Uniformity of weight.pH | CDL, KolkataCDSCO lab |
| Vitamin B-complex with Lysin & Calcium Pantothenate Syrup 100 ml | Batch BP-134Mfg May 2025 · Exp Oct 2026 | Amba Research LaboratoriesBihar | The sample does not conform to claim as per Schedule V of Drugs and Cosmetics Act 1940 with respect to Assay of Thiamine Hydrochloride.Assay | CDL, KolkataCDSCO lab |
| Terbutaline Sulphate, Ambroxol Hydrochloride Guaiphenesin & Menthol Syrup, | Batch OL25629Mfg Sep 2025 · Exp Aug 2027 | Saintlife Pharmaceuticals Ltd AN ISO-9001 2015/QMS Cert.Co WHO & GMP Certified CompanyUttarakhand | The sample received does not conform to manufacturers specification with respect to the Description only.Description | CDTL,HyderabadCDSCO lab |
| Terbutaline,Ambroxol,Guaiphenesin and Levomenthol Syrup | Batch S122509Mfg Dec 2025 · Exp Nov 2028 | Aglowmed LtdUttarakhand | The sample does not conform to claim with respect to the Assay of Levomenthol.Assay | CDL, KolkataCDSCO lab |
| Telmisartan Tablets IP 40mg, | Batch 384TTF055Mfg May 2025 · Exp Apr 2027 | Swiss Garnier Life Sciences NO. 21-23Himachal Pradesh | The sample does not conform to claim as per IP 2022 and Addendum 2024 in respect to the Test of DissolutionDissolution | RDTL, ChandigarhCDSCO lab |
| Telmisartan Tablets IP 40 mg | Batch 2513000079Mfg Aug 2025 · Exp Aug 2027 | Alembic Pharmaceuticals LtdSikkim | The sample does not conform to I.P. w.r.to the tests for Dissolution & AssayAssay | SDTL, AssamState lab |
| Telmisartan Tablets IP 40 Mg | Batch BPLT-25104Mfg May 2025 · Exp Apr 2027 | Bennet Pharmaceuticals LtdHimachal Pradesh | The sample does not conform to I.P. w.r.to the tests for Dissolution.Dissolution | SDTL, AssamState lab |
| Telmisartan Tab I.P 40 mg | Batch GT-2508Mfg Mar 2025 · Exp Feb 2027 | Helax Health Care Pvt. LtdUttarakhand | SAMPLE DOES NOT CONFIRM TO IP.Other | Directorate of State Drugs Control & Research Laboratory ,2 , Convent Lane, Kol-15State lab |
| Telmisartan & Amlodipine Tablets IP | Batch BPF251519Mfg Jun 2025 · Exp May 2027 | Aristo Pharmaceuticals Pvt. LtdHimachal Pradesh | The sample does not conform to I.P. w.r.to the tests for Identification and Assay SpuriousAssay | SDTL, AssamState lab |
| Sorbitol 70% IP (Non Crysallizing) | Batch KA/017Mfg Aug 2025 · Exp Aug 2030 | Gujarat Ambuja Exports LtdGujarat | The sample received does not conform to IP 2022 specification with respect to the content of ethylene glycol impurity, which is exceeding permissible limitOther | CDTL,HyderabadCDSCO lab |
| Sodium Chloride (0.9% w/v) & Dextrose (5%w/v) Injection IP | Batch PT25DNS2148CMfg Nov 2025 · Exp Oct 2028 | Promea Therapeutics Private LimitedTelangana | Test for SterilitySterility | DTL, Bengaluru, KarnatakaState lab |
| Sodium Bicarbonate Enteric Coated Tablets 500 mg | Batch STG-250674Mfg Jan 2025 · Exp Jan 2027 | Supermax Drugs & Pharmaceuticals Pvt. Ltd.(Unit-II)Uttarakhand | The sample does not confirm to claim as per Patent & Proprietory in respect to the Disintegration Test.Disintegration | DTL BaddiState lab |
| Sitagliptin & Metformin Prolonged-Release Tablets BP | Batch AXC0111Mfg Jul 2025 · Exp Jun 2027 | Exemed Pharmaceuticals | The sample does not conform to B.P. with respect to the Assay of Sitagliptin.Assay | CDL, KolkataCDSCO lab |
| Rosuvastatin with Fenofibrate Tablets | Batch RDF-2504Mfg Jun 2025 · Exp Jun 2027 | Life Line Pharma 188/1Puducherry | MISBRANDED DRUG In the composition the label should be mentioned as Rosuvastatin and Fenofibrate tablets IP. But the label is mentioned as only Rosuvastatin and Fenofibrate tablets. Hence it is Misbranded drug as per section 17 of Drugs and Cosmetics Act 1940.Misbranded | State Lab, DCL, TelanganaState lab |
| Rolled Bandage, Schedule F (II) | Batch 26Mfg Apr 2025 · Exp Apr 2028 | Karunamoorthy Surigcals AyyanapuramTamil Nadu | The sample does not complies for test parameyters1. Length 2,Width 3. Warp and 4.Weight in Grams/Sq.MetWeight | State Lab, DCL, TelanganaState lab |
| Ramipril Tablets IP 2.5 mg | Batch BPRA25002Mfg Apr 2025 · Exp Mar 2027 | Ravian Life Sciences Pvt. LtdUttarakhand | Test for Dissolution and Assay for RamiprilAssay | DTL, Bengaluru, KarnatakaState lab |
| Ramipril Tablets I.P. 1.25mg | Batch MLS-24943Mfg Oct 2025 · Exp Sep 2026 | Nexkem Pharmaceuticals Pvt. LtdUttarakhand | Content of Ramipril & Dissolution testDissolution | SDT&RL, BhubaneswarState lab |
| Rabeprazole Sodium Tablets | Batch T24.398Mfg Aug 2024 · Exp Jul 2026 | Oaksun LifesciencesTelangana | Dissolution test under acid & Buffer stageDissolution | SDT&RL, BhubaneswarState lab |
| Rabeprazole Sodium Injection IP 20mg/vial | Batch MD24E34Mfg May 2024 · Exp Apr 2026 | Martin & Brown Bio-Sciences Pvt. LtdHimachal Pradesh | The sample does not conform to I.P with respect to the tests of pH, Particulate matter, Clarity of Solution and Assay of Rabeprazole SodiumAssay | CDL, KolkataCDSCO lab |
| Rabeprazole Sodium Injection I.P. 20 mg/vial | Batch MD24K17Mfg Nov 2024 · Exp Oct 2026 | Martin & Brown Bio-Sciences Pvt. LtdHimachal Pradesh | The sample does not conform to I.P. with respect to the tests of Description, Clarity of solution, Particulate matter, pH, Related substances and Assay of Rabeprazole SodiumAssay | CDL, KolkataCDSCO lab |
| R Zara-DSR Capsules | Batch SC-05856Mfg Oct 2025 · Exp Sep 2027 | Samay Pharma India Pvt. LtdHimachal Pradesh | SPURIOUS 1.The sample fails in the test for Identification & also the Assay contents of Rabeprazole Sodium IP & Domperidone IP are found NIL. 2.The sample is also found Misbranded as Sunset Yellow in the label needs to be mentioned Sunset Yellow FCF.Assay | MDTL KathuaState lab |
| Prem Dulhan Fast Colour Cone (For Fast & Dark Colour) | Batch PD07AMfg Jul 2025 · Exp Jun 2026 | Prem Green Pvt. Ltd | The sample fails to comply in respect of labelling as per cosmetic Act.Labelling | DTL BhopalState lab |
| Povidone-Iodine Solution IP (10%) | Batch RSPI25091BMfg Sep 2025 · Exp Aug 2027 | Rsons Medikits India 5-5-35/275/2Telangana | Assay for available Iodine does not complies as per IP 2022 monograph.Assay | State Lab, DCL, TelanganaState lab |
| Pepsin & Fungal Diastase Syrup | Batch SPA250909Mfg Apr 2025 · Exp Sep 2026 | Skymap Pharmaceuticals Pvt. LtdUttarakhand | The sample does not conform to Manufacturer's Specification with respect to Test for Identification and Assay of Pepsin activityAssay | CDL, KolkataCDSCO lab |
| Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Suspension125mg/5mg/1mg (60ml) | Batch PRL2501-03Mfg Jan 2025 · Exp Dec 2026 | Regent Ajanta BiotechUttarakhand | The sample received does not conform to Manufacturers specification with respect to the test for Description and Assay of Phenyleprhine hydrochloride.Assay | CDTL, MumbaiCDSCO lab |
| Paracetamol, Phenyephrine hydrochloride, Chlorpheniramine Maleate, Sodium Citrate & Menthol Suspension | Batch 241175Mfg Nov 2024 · Exp Oct 2026 | True Life Pharma Pvt. Ltd | Phenyephrine hydrochloride contentOther | FDL, VadodaraState lab |
| Paracetamol Tablets IP 650 mg | Batch G02090BMfg Jan 2025 · Exp Dec 2026 | Growmed Life PharmaGujarat | The sample does not conform to IP with respect to the test of Dissolution.Dissolution | CDL, KolkataCDSCO lab |
| Paracetamol Tablets IP 650 mg | Batch CAAL25054Mfg Dec 2025 · Exp Nov 2028 | Curetech Formulations Pvt. LtdHimachal Pradesh | DissolutionDissolution | DTL, PuducherryState lab |
| Paracetamol Tablets IP 500mg | Batch IPCL25031Mfg May 2025 · Exp Apr 2028 | Pinnacle Klife Science Private LimitedHimachal Pradesh | The sample does not conform to I.P. w.r.to the tests for Dissolution.Dissolution | SDTL, AssamState lab |
| Paracetamol Tablets IP | Batch 2506006Mfg Jun 2025 · Exp May 2028 | Aban PharmaceuticalsKerala | The samole does not comply with IP requirment for the Dissolution test.Dissolution | FDAL, MumbaiState lab |
| Paracetamol Tablets BP 500mg | Batch RHR069Mfg Dec 2025 · Exp Nov 2028 | Rathod Pharmachem Private LimitedGujarat | The sample received does not conform to b.p. 2025 specification with respect to the test for DissolutionDissolution | CDTL,HyderabadCDSCO lab |
| Pantoprazole Sodium Tablets 40 mg | Batch T24.240Mfg May 2024 · Exp Apr 2026 | Oaksun LifesciencesTelangana | Dissolution (buffer stage)Dissolution | SDT&RL, BhubaneswarState lab |
| Pantoprazole Gastro-resistant & Domperidone Prolonged-release Capsules IP | Batch AGC240287Mfg Jan 2025 · Exp Dec 2026 | Asterisk Healthcare | The sample does not conform to IP and Manufacturer's Specification with repect to the test of Dissolution of Domperidone.Dissolution | CDL, KolkataCDSCO lab |
| Pantoprazole Gastro ? Resistant & Domperidone Prolonged ? Release Capsules IP | Batch KC25G002Mfg Jul 2025 · Exp Jun 2027 | Keylink Global Exim Pvt. LtdHimachal Pradesh | The sample does not conform to Standard Quality in respect of the tests for Dissolution in Buffer stage performed.Dissolution | SDTL, TripuraState lab |
| Pantoprazole & Domperidone Tablet | Batch GT501287aMfg Nov 2025 · Exp Oct 2027 | Gnosis Pharmaceuticals Pvt. Ltd. Nahan RoadHimachal Pradesh | The sample does not comply with IP requirment for the Dissolution -A for PantoprazoleDissolution | FDAL, MumbaiState lab |
| Pantoprazole & Domperidone Capsules IP | Batch SPJ241197Mfg Sep 2024 · Exp Aug 2026 | Aristo Pharmaceuticals Pvt. LtdHimachal Pradesh | The sample does not conform to I.P. w.r.to the tests for Identification and Assay SpuriousAssay | SDTL, AssamState lab |
| Oxetacaine, Dried Aluminium Hydroxide gel & Magnesium Hydroxide oral Suspension | Batch SP25411Mfg May 2025 · Exp Apr 2027 | Seejar Pharmaceuticals | Assay for Oxetacaine, Dried Aluminium Hydroxide gel & Magnesium HydroxideAssay | DTL, Bengaluru, KarnatakaState lab |
| Ofloxacin 100mg, Ornidazole 2500mg & Loperamide 7.5mg Bolus IP | Batch DF-1677Mfg Sep 2025 · Exp Aug 2027 | Dutch Formulations 32Himachal Pradesh | Assay of Ofloxacin, Ornidazole & LoperamideAssay | CFDL JammuState lab |
| Ofloxacin & Ornidazole Tablets IP | Batch E50058Mfg Jan 2025 · Exp Dec 2028 | Medley Pharmaceuticals LtdJammu & Kashmir | The sample does not conform to I.P. w.r.to the tests for Dissolution And AssayAssay | SDTL, AssamState lab |
| Nifedipine Sustained Released Tablet IP | Batch NR019Mfg Nov 2024 · Exp Oct 2026 | Nabros Pharma Pvt. Ltd | DissolutionDissolution | FDL, VadodaraState lab |
| Montelukast Sodium and Levocetirizine Dihydrochloride Syrup | Batch SP25990Mfg Oct 2025 · Exp Sep 2027 | Seejar Pharmaceuticalls | Assay for MontelukastAssay | DTL, Bengaluru, KarnatakaState lab |
| Misoprostol Tablets IP 200 mcg | Batch BGW02AAAMfg Feb 2025 · Exp Jan 2027 | Akums Drugs & Pharmaceuticals LtdUttarakhand | The sample does not conform I.P with respect to the Assay of MisoprostolAssay | CDL, KolkataCDSCO lab |
| Metjeel 25 XL (Metoprolol Succinate Prolonged Released Tablet I.P) | Batch TN - 5974Mfg Sep 2025 · Exp Aug 2027 | Helax Health Care Pvt. LtdUttarakhand | 1) SAMPLE DOES NOT CONFIRM TO IP. 2) The sample strip shows the product name " METJEEL 25XL" where the inspection memo shows it "Meetjeel 25XL"Other | Directorate of State Drugs Control & Research Laboratory ,2 , Convent Lane, Kol-15State lab |
| Methylprednisolone Tablets IP 4mg | Batch T252005Mfg Jul 2025 · Exp Jun 2027 | United Bioceuticals Pvt. LtdUttarakhand | The sample does not conform to the IP with respect to in Assay & Dissolution of Methylprednisolone.Assay | DTL JaipurState lab |
| Methyl Prednisolone Tablets IP 4mg | Batch B2508249BMfg Aug 2025 · Exp Jul 2027 | Bymaa Laboratories Private LimitedPuducherry | The sample fails the test 'Dissolution' as per IPDissolution | DTL ThiruvananthapuramState lab |
| Metformin Hydrochloride Prolonged Release and Glimepiride Tablets IP | Batch T5107Mfg Jul 2025 · Exp Jun 2027 | Merril Pharma Pvt. LtdGujarat | The sample does not conform to IP with respect to the Test of Dissolution for Glimepiride.Dissolution | CDL, KolkataCDSCO lab |
| Metformin Hydrochloride Prolonged Release and Glimepiride Tablets IP | Batch T5110Mfg Jul 2025 · Exp Jun 2027 | Merril Pharma Pvt. LtdGujarat | The sample does not conform to IP with respect to the test of Dissolution of Glimepiride.Dissolution | CDL, KolkataCDSCO lab |
| Mehandi Cone | Batch PMC1744Mfg Dec 2025 · Exp Nov 2026 | Pushp Henna Pvt. Ltd | The Sample does not conform to claim as per IS 17318:2020 in respect to the Test of Total viable count.Other | RDTL ChandigarhState lab |
| Loperamide Hydrochloride Tablets IP 2mg | Batch GTE1588Mfg May 2025 · Exp Apr 2027 | Gidsha PharmaceuticalsGujarat | Misbranded-Incorrect LabellingMisbranded | DTL, PuducherryState lab |
| Loperamide Hydrochloride Capsules I.P | Batch C-2127Mfg Dec 2024 · Exp Nov 2026 | Supercure Biotech Pvt. LtdHaryana | Dissolution TestDissolution | DTL, Bengaluru, KarnatakaState lab |
| Liquid Paraffin IP 100 ml | Batch 208Mfg Dec 2025 · Exp May 2028 | Repacked by- Medi Smith Pharma LabKarnataka | The sample fails the test Light Absorption as per IPOther | DTL ThiruvananthapuramState lab |
| Levosalbutamol, Ambroxol & Guaiphenesin Syrup | Batch L25071Mfg Nov 2024 · Exp Oct 2026 | Tuttsan Pharma Pvt. Ltd | Guaiphenesin ContentOther | FDL, VadodaraState lab |
| Levosalbutamol, Ambroxol Hydrochloride HCl & Guaiphenesin Syrup | Batch SL241141JMfg Nov 2024 · Exp Oct 2026 | Star Filteration SystemsHimachal Pradesh | The sample does not conform to claim with respect to the tests of Uniformity of Volume and Assay of Ambroxol Hydrochloride.Assay | CDL, KolkataCDSCO lab |
| Levocetirizine Hydrochloride and Montelukast Sodium Tablets IP (5 mg/10 mg) | Batch 310225017Mfg May 2025 · Exp Apr 2027 | Ravenbhel Healthcare Pvt. LtdJammu & Kashmir | DescriptionDescription | DTL, Bengaluru, KarnatakaState lab |
| Ketoconazole Tablets IP 200 mg | Batch AD00112001Mfg Jan 2025 · Exp Dec 2026 | Admed Pharma Pvt. LtdHimachal Pradesh | DescriptionDescription | DTL, Bengaluru, KarnatakaState lab |
| Itraconazole Capsules USP 100 mg | Batch ITR 19Mfg Jul 2025 · Exp Jun 2027 | Bal Pharma LtdKarnataka | The sample does not conform to U.S.P. with respect to Dissolution test.Dissolution | CDL, KolkataCDSCO lab |
| Iron Sucrose Injection USP 5 Ml | Batch MA24G50Mfg Jul 2024 · Exp Jun 2026 | Martin & Brown Bio-Sciences Pvt. LtdHimachal Pradesh | The sample does not conform to U.S.P with respect to the tests of pH, Alkalinity and Particulate matter.Particulate matter | CDL, KolkataCDSCO lab |
| Iron Sucrose Injection USP 100mg/5ml | Batch 25488Mfg Dec 2025 · Exp Nov 2027 | T. Walkers Pharmaceuticals Pvt. LtdMaharashtra | The sample does not conform to U.S.P with respect to test for pH and Alkalinity.pH | CDL, KolkataCDSCO lab |
| Ibuprofen and Paracetamol Tablets IP | Batch TB251005Mfg Dec 2025 · Exp Nov 2027 | Agron Remedies Pvt. Ltd. SarverkheraUttarakhand | The sample fails in the Test for DescriptionDescription | MDTL KathuaState lab |
| Ibuprofen And Paracetamol Tablets IP | Batch ISW24176Mfg Aug 2024 · Exp Jul 2027 | IBN Herbals (A unit of curetech formulation (P) Ltd) Khasara No. 63Himachal Pradesh | DisintegrationDisintegration | DTL, PuducherryState lab |
| INFUSION SET | Batch G25I020339Mfg Sep 2025 · Exp Aug 2030 | Romsons Group Pvt. Ltd | The sample does not conform to manufacturer specification and ISO 8536-4 with respect to sterility.Sterility | CDL, KolkataCDSCO lab |
| Hyoscine Butylbromide Injection IP | Batch HLI591HMfg Aug 2025 · Exp Jul 2028 | Himalaya Meditek Pvt. LtdUttarakhand | The sample does not conform to claim as per IP 2022 in respect to the Test of Particulate matter.Particulate matter | RDTL, ChandigarhCDSCO lab |
| Glimepiride Tablets IP | Batch AMT-2153Mfg Sep 2025 · Exp Aug 2027 | Avalon Medicines Pvt. LtdHaryana | The sample fails the test 'Dissolution' as per IPDissolution | DTL ThiruvananthapuramState lab |
| Flunixin Meglumine Injection 50mg/ml | Batch AFM-02Mfg Oct 2025 · Exp Sep 2027 | Agron Remedies Pvt. Ltd. SarverkheraUttarakhand | DescriptionDescription | DTL, Bengaluru, KarnatakaState lab |
| Ferrous Ascorbate and Folic Acid Tablet | Batch NAC25006Mfg Nov 2025 · Exp Oct 2027 | Nuvista Pharmaceuticals Pvt.LtdTelangana | 1. Assay for Elemental Iron Does not complies as per IP 2022. 2. In the compostion the label should be mentioned as Ferrous Ascorbate and Folic Acid IP. But the label is mentioned as only Ferrous Ascorbate and Folic Acid. The letters IP is not mentioned on the strip. 3. In the compostion it should be mentioned as Ferrous Ascrobate equivalent to Elemental Iron, but it is labelled as only Ferrous Ascorbate 100 mg.Assay | State Lab, DCL, TelanganaState lab |
| Esomeprazole Tablets IP | Batch ZTF-037AMfg Jun 2025 · Exp May 2027 | Zoic Biotech Pvt .LtdPunjab | The sample fails the test 'Dissolution' as per IPDissolution | DTL KonniState lab |
| Esomeprazole Tablets IP | Batch AYT070385Mfg Jul 2025 · Exp Jun 2027 | Adwin PharmaHimachal Pradesh | The sample does not conform to IP 2022 requirements w.r.t Dissolution TestDissolution | DTL,Dalgate Srinagar kashmirState lab |
| Erythromycin Stearate Tablets IP | Batch ATG5K933Mfg Nov 2025 · Exp Oct 2027 | Anrose PharmaHimachal Pradesh | DescriptionDescription | DTL, PuducherryState lab |
| Enteric Coated Rabeprazole Sodium 20 mg & Domperidone Sustained Release 30 mg Capsules | Batch 404F004Mfg Nov 2024 · Exp Oct 2026 | Inventia Healthcare LimitedMaharashtra | Rabeprazole Sodium ContentOther | FDL, VadodaraState lab |
| Doxylamine Succinate & Pyridoxine Hydrochloride Tablets | Batch DXM2534Mfg Jul 2025 · Exp Jun 2028 | Maneesh Pharmaceuticals LtdHimachal Pradesh | The sample received does not conform to Manufacturers specification with respect to the test for ThicknessOther | CDTL, MumbaiCDSCO lab |
| Divalproex Sodium Extended-release Tablets IP | Batch N2407172Mfg Jul 2024 · Exp Jun 2026 | Talent HealthcareUttarakhand | The sample does not conform to I.P. for the reason stated under Description.Description | CDL, KolkataCDSCO lab |
| Disinfectant Fluid Black Phenolic Type Normal Grade-1 | Batch MCI040Mfg Jun 2024 · Exp May 2026 | Mittal Chemical Industries | The sample does not conform to claim as per Drugs and Cosmetics Act - Schedule O and IS 1061:2017 with respect to Grade and Germicidal Value.Other | CDL, KolkataCDSCO lab |
| Diclofenac Sodium Injection I.P. 75 mg/2ml | Batch VB/LEF0789Mfg Jul 2025 · Exp Jun 2027 | Venus Bio Sciences Pvt. LtdHimachal Pradesh | The sample does not conform to I.P. with respect to the tests of Identification and Assay of Diclofenac Sodium. The sample gives positive test for Identification of Buprenorphine. The sample is deemed to be spurious vide section 17 B of Drugs and Cosmetics Act 1940 and Rule 1945.Assay | CDL, KolkataCDSCO lab |
| Diclofenac Sodium & Paracetamol Tablets | Batch TL30162Mfg Jan 2024 · Exp Dec 2026 | Taurus Life Sciences LtdGujarat | The sample is not of standard quality with respect to the reason stated under Description.Description | CDTL,IndoreCDSCO lab |
| Diazepam Injection I.P. 2ml | Batch DA-2412Mfg Feb 2025 · Exp Jan 2027 | Systochem Laboratories LtdUttar Pradesh | The sample does not conform to I.P. with respect to the tests of Identification of Diazepam, Particulate matter, pH, Assay of Diazepam and for the reason stated under Description.Assay | CDL, KolkataCDSCO lab |
| Diabit-GM | Batch T25F640AMfg Jun 2025 · Exp May 2027 | Bajaj FormulationsUttarakhand | The sample fails in the Test for DescriptionDescription | MDTL KathuaState lab |
| Dextromethorphan hydrobromide, phenylephrine hydrochloride & Chlorpheniramine Maleate Syrup | Batch L 24371Mfg Nov 2024 · Exp Oct 2026 | KNM Pharma Pvt. LtdGujarat | Microbial Contamination (Total Aerobic Viable Count)Microbial limits | FDL, VadodaraState lab |
| Dextromethorphan hydrobromide, phenylephrine hydrochloride & Chlorpheniramine Maleate Syrup | Batch L 24326Mfg Nov 2024 · Exp Oct 2026 | KNM Pharma Pvt. LtdGujarat | Microbial Contamination (Total Aerobic Viable Count)Microbial limits | FDL, VadodaraState lab |
| Dextromethorphan Hbr & Chlorphenramine Maleate Syrup | Batch TLLM-188Mfg Dec 2024 · Exp Nov 2026 | Taksa Lifesciences Pvt. LtdPunjab | The sample does not conform to the claim with respect to Assay of Chlorpheniramine Maleate.Assay | DTL JaipurState lab |
| Dexamethasone sodium Phosphate Injection IP | Batch DIH-227/10Mfg Oct 2025 · Exp Sep 2027 | Indo Gulf Pharmaceuticals 5.4 Km | The sample does not conform to IP 2022 requirements w.r.t Sterility TestSterility | DTL,Dalgate Srinagar kashmirState lab |
| Dexamethasone Sodium Phosphate Injection IP | Batch UMI25267Mfg Oct 2025 · Exp Sep 2027 | Ultramark Healthcare Pvt. LtdPunjab | The sample does not conform to IP with respect to tests for Particulate matter, Free Dexamethasone, Sterility and Assay of Dexamethasone Phosphate, and is also not of standard quality for the reason stated under Description.Assay | CDL, KolkataCDSCO lab |
| Deflazacort Oral Suspension | Batch JLL2526Mfg Dec 2025 · Exp Nov 2027 | Janveda Healthceutical Pvt. LtdGujarat | The sample does not conform to claim as per Manufacture's Specification with respect to the Assay of Deflazacort.Assay | CDTL,IndoreCDSCO lab |
| Cyproheptadine Hydrochloride Syrup I.P. | Batch SR-086Mfg Dec 2024 · Exp Nov 2026 | Sresan Pharmaceutical Manufacturer 787Karnataka | Content of Cyproheptadine HCIOther | SDT&RL, BhubaneswarState lab |
| Coral Calcium & Vitamin D3 Tablets | Batch MLS-251719Mfg Feb 2026 · Exp Jan 2028 | Maskon Life Sciences Pvt. LtdUttarakhand | The sample does not conform to the claim with respect to Assay of Vitamin D3 (Nil).Assay | DTL JaipurState lab |
| Compound Sodium Lactate Injection Ip (Ringer Lactate Solution For Injection IP | Batch OM251102Mfg Nov 2025 · Exp Oct 2027 | Haseeb Pharmaceuticals Pvt. LtdMaharashtra | The sample does not comply as per I.P. 2022 with respect to the BETOther | RDTL, GuwahatiCDSCO lab |
| Compound Sodium Lactate Injection IP | Batch 03BF2084Mfg Jun 2023 · Exp May 2026 | Paschim Banga Pharmaceuticals | The sample does not conform to I.P. with respect to test for SterilitySterility | CDL, KolkataCDSCO lab |
| Combi Pack of Vitamin C Injection I.P. With Methylcobalamin, Folic Acid & Niacinamide Injection | Batch WZ-4817A&BMfg Sep 2025 · Exp Feb 2027 | Sunvet Pharma Pvt. LtdHimachal Pradesh | The sample does not conform to Manufacturer's Specification and IP with respect to test for pH, Particulate Matter and is also not of standard quality for the reason stated under Description.Description | CDL, KolkataCDSCO lab |
| Ciprofloxacin Tablets I.P. 500 mg | Batch GT50135Mfg May 2025 · Exp Apr 2028 | Omega PharmaUttarakhand | The sample does not conform to the IP with respect to Assay and Dissolution of Ciprofloxacin Hydrochloride Equivalent to Ciprofloxacin.Assay | DTL JaipurState lab |
| Cetirizine Hydrochloride Tablets I.P. 10mg | Batch LPT2425300Mfg Feb 2025 · Exp Jan 2027 | Lannett Pharmaceuticals Pvt. Ltd | DescriptionDescription | DTL, Bengaluru, KarnatakaState lab |
| Cefuroxime Axetil Tablets IP | Batch VT252942Mfg Mar 2026 · Exp Feb 2028 | VADSP PharmaceuticalsHimachal Pradesh | The sample does not conform to the IP with respect to Assay.Assay | DTL JaipurState lab |
| Cefuroxime Axetil Tablets I.P. | Batch SSTG25503Mfg Jan 2026 · Exp Dec 2027 | Shri Sai Balaji Pharmatech Pvt Ltd. 20 Ext HPSIDC Ind. Area Baddi H.PHimachal Pradesh | AssayAssay | DTL Baddi Distt. Solan HPState lab |
| Cefpodoxine Proxetil Tablets IP | Batch VT242312Mfg Dec 2024 · Exp Nov 2026 | VADSP PharmaceuticalsHimachal Pradesh | The sample does not conform to the IP as it does not contain Cefpodoxime (Nil)Other | DTL JaipurState lab |
| Cefpodoxime Tablets IP 200 Mg | Batch BPA250167Mfg Jan 2025 · Exp Dec 2026 | Aristo Pharmaceuticals Pvt. LtdHimachal Pradesh | The sample does not conform to I.P. w.r.to the tests for Identification and Assay SpuriousAssay | SDTL, AssamState lab |
| Cefixime Tablets IP 200 mg | Batch 25460922Mfg May 2025 · Exp Apr 2027 | Alkem Health ScienceSikkim | The sample does not conform to I.P. w.r.to the tests for Identification and Assay SpuriousAssay | SDTL, AssamState lab |
| Cefixime & Potassium Clavulanate Tablets | Batch MYRTAB-971Mfg Mar 2025 · Exp Oct 2026 | Mayer LabHimachal Pradesh | Assay for Clavulanic acidAssay | DTL, Bengaluru, KarnatakaState lab |
| Calcium and Vitamin D3 Tablets IP | Batch HCL5154Mfg Apr 2025 · Exp Mar 2027 | Hanuchem LaboratoriesHimachal Pradesh | Assay for Vitamin D3Assay | DTL, Bengaluru, KarnatakaState lab |
| Calcium & Vitamin D3 Tablets | Batch 24443315Mfg Sep 2024 · Exp Aug 2026 | Alkem Health ScienceSikkim | The sample does not conform to I.P. w.r.to the tests for Dissolution & AssayAssay | SDTL, AssamState lab |
| Calamine Lotion� | Batch 021Mfg Dec 2024 · Exp Nov 2026 | Medivin (India) Pharma LabKarnataka | Assay for Calamine (Zinc Oxide) and Liquid ParaffinAssay | DTL, Bengaluru, KarnatakaState lab |
| Buprenorphine Injection IP 2ml | Batch BUP325007Mfg Sep 2025 · Exp Aug 2027 | Indus Pharma Pvt. LtdRajasthan | The sample does not conform to I.P. with respect to the test of Particulate Matter and for the reason stated under Description.Description | CDL, KolkataCDSCO lab |
| Buprenorphine Injection IP | Batch ASG1590Mfg Nov 2022 · Exp Oct 2026 | SNG Pharmaceuticals (p) Ltd | The sample does not conform to I.P. with respect to tests of Sterility and Assay of Buprenorphine.Assay | CDL, KolkataCDSCO lab |
| Bromhexine Hydrochloride,Terbutaline Sulphate,Guaiphenesin & Menthol Syrup | Batch R02GL2529Mfg Jan 2025 · Exp Dec 2026 | Rednex Pharmaceuticals Pvt. LtdKerala | The sample does not conform to claim as per Manufacturer method & specification in respect to the Assay of MentholAssay | CDL, KolkataCDSCO lab |
| Azithromycin Oral Suspension 100 ml | Batch 25243Mfg Jul 2025 · Exp Jun 2027 | HYT Formulations 1st 2nd & rd Floors RoomTelangana | The sample does not meets the Specification wrt. Assay of Azithromycin as per STP.Assay | State Lab, DCL, TelanganaState lab |
| Aspirin Gastro-Resistant Tablets IP 75mg | Batch ANET1243Mfg May 2024 · Exp Apr 2026 | Unicure India LtdUttar Pradesh | The Sample fails the test 'Descriptive Part, Dissolution, Salicylic Acid and Assay as per IPAssay | DTL ThiruvananthapuramState lab |
| Amoxycillin and Potassium Clavulanate Tablets IP | Batch BYC0043Mfg Aug 2025 · Exp Jan 2027 | Sun Pharmaceuticals Ind. LtdMaharashtra | The sample does not conform to standard in respect of the test for Dissolution of Amoxycillin performed.Dissolution | SDTL, TripuraState lab |
| Amoxycillin and Potassium Clavulanate Tablets IP | Batch 25442306Mfg Jun 2025 · Exp Nov 2026 | Alkem Health ScienceSikkim | The sample does not conform to standard quality in respect of the test for ?Dissolution of Amoxycillin and Assay for Clavulanic Acid performed.Assay | SDTL, TripuraState lab |
| Amoxycillin and Potassium Clavulanate Tablets IP | Batch CF10077Mfg Mar 2025 · Exp Aug 2026 | Finecure Pharmaceuticals LtdGujarat | The sample does not conform to standard in respect of the test for Dissolution of Amoxycillin performed.Dissolution | SDTL, TripuraState lab |
| Amoxycillin Potassium Clavulanate & Lactic Acid Bacillus Tablets | Batch VT252296Mfg Dec 2025 · Exp May 2027 | VADSP PharmaceuticalsHimachal Pradesh | The sample does not conform to the claim as it does not contain Clavulanic Acid (Nil).Other | DTL JaipurState lab |
| Amoxycillin & Potassium Clavulanate Tablets IP | Batch ABT25223Mfg Aug 2025 · Exp Jan 2027 | Plot No. 20Himachal Pradesh | The content of Amoxycillin in the sample is less(i.e.49.79% of stated amount) and the content of clavulanic acid in the sample is less (i.e.6.56% of the stated amount) than IP limit. (IP Limit-Not less than 90% and Not more than 120% of stated amount) The content of Clavulanic Acid in the sample is less (i.e 29.38% of stated amount) than the IP limit (IP limit not less than 80% of sated amount) 2. The sample does not comply with IP requirements for the Dissolution test of Amoxicillin and Clavulanic AcidDissolution | FDAL, MaharashtraState lab |
| Ambroxol Hydrochloride, Levosalbutamol & Guaiphenesin Drops | Batch GLF0712BMfg Jul 2025 · Exp Jun 2027 | Digital VisionHimachal Pradesh | The sample does not conform to the claim with respect to Assay.Assay | DTL JaipurState lab |
| Albendazole Tablets IP 400mg | Batch 296725043Mfg Apr 2025 · Exp Mar 2027 | Ravenbhel Healthcare Pvt. Ltd. 16-17Jammu & Kashmir | The sample does not conform to IP 2022 requirements w.r.t Dissolution TestDissolution | DTL,Dalgate Srinagar kashmirState lab |
| Albendazole Tablets IP 400 mg | Batch MT250998Mfg Oct 2025 · Exp Sep 2027 | Mancare Laboratories Pvt. LtdUttarakhand | The sample does not conform to I.P. with respect to test for DissolutionDissolution | CDL, KolkataCDSCO lab |
| Albendazole Tablets IP | Batch PGT24427Mfg Jul 2024 · Exp Jun 2027 | Affy ParenteralsHimachal Pradesh | The sample does not conform to the IP with respect to Dissolution.Dissolution | DTL JaipurState lab |
| Albendazole Tablets I.P. 400 mg | Batch MT250995Mfg Oct 2025 · Exp Sep 2027 | Mancare Laboratories Pvt. LtdUttarakhand | The sample does not conform to I.P. with respect to test for Dissolution.Dissolution | CDL, KolkataCDSCO lab |
| Albendazole Tablets I.P. 400 mg | Batch MT250996Mfg Oct 2025 · Exp Sep 2027 | Mancare Laboratories Pvt. LtdUttarakhand | The sample does not conform to I.P. with respect to test for Dissolution.Dissolution | CDL, KolkataCDSCO lab |
| Albendazole Tablets I.P. 400 mg | Batch MT250994Mfg Oct 2025 · Exp Sep 2027 | Mancare Laboratories Pvt. LtdUttarakhand | The sample does not conform to I.P. with respect to test for DissolutionDissolution | CDL, KolkataCDSCO lab |
| Activated Teeth Whitening Powder with Charcoal | Batch DC5092Mfg Nov 2024 · Exp Oct 2026 | DentiglowGujarat | Total Microbial Count & Total Yeast and Mould CountMicrobial limits | FDL, VadodaraState lab |
| Aceclofenac, Paracetamol and Serratiopeptidase Tablets | Batch C24T140EMfg Jan 2025 · Exp Dec 2026 | Cartel LaboratoriesTelangana | Assay for SerratiopeptidaseAssay | DTL, Bengaluru, KarnatakaState lab |
| Absorbent Gauze IS 758 | Batch 183Mfg Aug 2025 · Exp Jul 2028 | Sri Vishnuram Company 759/15Tamil Nadu | The sample does not complies for test parameters 1. Threads per dm 2.Length 3. Width and 4.Weight In Gm/Sq.Met.Weight | State Lab, DCL, TelanganaState lab |
| Absorbent Cotton Wool IP | Batch 2085Mfg Mar 2025 · Exp Feb 2027 | Jind SurgicalsHaryana | The sample is not of standard quality for the reason stated under Description.Description | RDTL, GuwahatiCDSCO lab |
| Absorbent Cotton Wool I.P | Batch 2085Mfg Mar 2025 · Exp Feb 2027 | Jind Surgicals 24-27Haryana | The sample is not of standard quality for the reason stated under DescriptionDescription | RDTL,GuwahatiState lab |
| ALPC Wellness Rosemary Water for thick Hair | Batch AR5112Mfg Nov 2024 · Exp Oct 2026 | AlpcGujarat | Total Microbial CountMicrobial limits | FDL, VadodaraState lab |
Suspected spurious batches in this alert
| Product | Batch | Labelled manufacturer | Reported by | Firm's reply |
|---|---|---|---|---|
| Ursodeoxycholic Acid Tablets IP | GTF2281A | Under Investigation | CDL, Kolkata | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
| L-Carnitine, L- Tartarate ,Mecobalamin & Folic Acid Tablets | B95Y032 | M/s: Mandkind Pharma Ltd., Doring Block, Bermiok Elaka, Dist. Namchi, Sikkim-737126 | SDTL, Assam | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
Check your medicine. Enter the batch number printed on the strip, bottle or carton to see whether it appears in this or any earlier alert. Check a batch number
Sources
- Regulator
- Regulator
Changelog
- 3 Nov 2026: table generated from the CDSCO NSQ portal export (121 rows). Revised CDSCO lists are diffed on each monthly rebuild.